Portions of this document have been redacted pursuant to a Request for Confidential Treatment. Redacted portions are indicated with the notation “[*****]” DEVELOPMENT AND INITIAL SUPPLY AGREEMENTDevelopment and Initial Supply Agreement • February 27th, 2004 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2004 Company IndustryWHEREAS, BioMarin is interested in developing Tetrahydrobiopterin for the treatment of genetic diseases such as phenylketonuria (PKU);